Questions arise over reference pricing system

Although the government reiterated the reference pricing system (RPS) will prevent the abuse of high-priced drugs and bring about a reduction in insurance cost, the pharmaceutical firms and civil groups oppose the plan, claiming that the new system will impair the sound drug market atmosphre and only serves to stabilize the National Health Insurance Corp. at the expense of patients, unless over...